Saniona
Manufacturing · Denmark · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Smedeland 26b, Glostrup, Capital Region,...Phone Number
+45 20289705Website
www.saniona.comRevenue
<$5 MillionStock Symbol
SANION.STIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Saniona
Saniona, founded in 2011 and headquartered in Glostrup, Denmark, is a biopharmaceutical company focused on discovering, developing, and delivering innovative treatments for rare disease patients around the world. The company’s lead product candidate, Tesomet, is in mid-stage clinical trials for the rare diseases Prader-Willi syndrome and hypothalamic obesity.Explore more
Saniona Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Saniona your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Saniona has new funding data
Congratulate Masked Content for being promoted to Masked Content at Saniona
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Saniona launches new products
Click to see if Saniona had a recent Job posting/layoffs
Check out if Saniona is spiking on competitors!
Check if Saniona has recently received funding, and reach out quickly before it becomes old news!
Saniona, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Saniona recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Saniona is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Saniona is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Saniona.
Saniona financials insights
Gather financial insights about Saniona, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Share Placement
$2.6M
Saniona Tech Stack
A closer look at the technologies used by Saniona
Most Recent Scoops
Project
Saniona has announced that SAN-2668 reduced aggressive behavior in preclinical studies by delaying the first attack and reducing attack duration, with locomotor activity unaffected, suggesting the effect was not caused by sedative or nonspecific effects.
Medical Research
Earnings
Saniona has reported operating expenses of SEK 65 million for Q2, an increase of SEK 4 million compared to the prior quarter.
Earnings, Finance
Earnings
Saniona has reported a net loss of SEK 58 million for Q2, in line with expectations, with the increase in costs driven by the progression of its two internal assets, SAN-2668 and SAN-2465, toward Phase I clinical trial initiation around year-end.
Project
Saniona has announced that SAN-2668 has demonstrated improvement in multiple non-seizure endpoints in preclinical studies, including cognitive impairment and aggression-related behavior in the SYNGAP1 model and social functioning in the CHD2 model, though caution is warranted regarding translation to patients.
Medical Research, Pharmaceuticals
Project
Research & Development
Saniona News & Media
Saniona Appoints New CFO to Strengthen Financial Strategy - TipRanks.com
The latest update is out from Saniona AB ( ($SE:SANION) ). Saniona has appointed Johnny Stilou as Chief Financial Officer, bringing over 25 years of financial leade...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Saniona
Sign Up For FreeTo access detailed company insights
Saniona, founded in 2011 and headquartered in Glostrup, Denmark, is a biopharmaceutical company focused on discovering, developing, and delivering innovative treatments for rare disease patients around the world. The company’s lead product candidate, Tesomet, is in mid-stage clinical trials for the rare diseases Prader-Willi syndrome and hypothalam... Read More
